{
     "PMID": "1387198",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19920922",
     "LR": "20161123",
     "IS": "0304-3940 (Print) 0304-3940 (Linking)",
     "VI": "141",
     "IP": "1",
     "DP": "1992 Jul 6",
     "TI": "Role of serotonin receptor subtype in seizures kindled from the feline hippocampus.",
     "PG": "21-4",
     "AB": "This study assessed the effects of a serotonin (5-HT)1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a 5-HT2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and a 5-HT2 antagonist ketanserin on fully kindled seizures from the hippocampus. 8-OH-DPAT produced a marked suppression in hippocampal kindled seizures, while producing behavioral signs similar to those seen in the 5-HT syndrome. Although DOI and ketanserin did not affect kindled focal epileptic activity, DOI shortened and ketanserin prolonged the latency to onset of generalized convulsions. Our data suggest that 5-HT1A receptors play an inhibitory role in the generation of hippocampal seizures, whereas 5-HT2 receptors may participate in kindled seizure generalization from this region.",
     "FAU": [
          "Wada, Y",
          "Nakamura, M",
          "Hasegawa, H",
          "Yamaguchi, N"
     ],
     "AU": [
          "Wada Y",
          "Nakamura M",
          "Hasegawa H",
          "Yamaguchi N"
     ],
     "AD": "Department of Neuropsychiatry, Kanazawa University School of Medicine, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Ireland",
     "TA": "Neurosci Lett",
     "JT": "Neuroscience letters",
     "JID": "7600130",
     "RN": [
          "0 (Amphetamines)",
          "0 (Anticonvulsants)",
          "0 (Hallucinogens)",
          "0 (Receptors, Serotonin)",
          "0 (Tetrahydronaphthalenes)",
          "78950-78-4 (8-Hydroxy-2-(di-n-propylamino)tetralin)",
          "97F9DE4CT4 (Ketanserin)",
          "OOM10GW9UE (4-iodo-2,5-dimethoxyphenylisopropylamine)"
     ],
     "SB": "IM",
     "MH": [
          "8-Hydroxy-2-(di-n-propylamino)tetralin",
          "Amphetamines/pharmacology",
          "Animals",
          "Anticonvulsants/pharmacology",
          "Cats",
          "Electric Stimulation",
          "Female",
          "Hallucinogens/pharmacology",
          "Hippocampus/*metabolism",
          "Ketanserin/pharmacology",
          "Kindling, Neurologic/*metabolism",
          "Male",
          "Receptors, Serotonin/*metabolism",
          "Seizures/*metabolism",
          "Tetrahydronaphthalenes/pharmacology"
     ],
     "EDAT": "1992/07/06 00:00",
     "MHDA": "1992/07/06 00:01",
     "CRDT": [
          "1992/07/06 00:00"
     ],
     "PHST": [
          "1992/07/06 00:00 [pubmed]",
          "1992/07/06 00:01 [medline]",
          "1992/07/06 00:00 [entrez]"
     ],
     "AID": [
          "0304-3940(92)90325-2 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Neurosci Lett. 1992 Jul 6;141(1):21-4.",
     "term": "hippocampus"
}